1998
DOI: 10.1038/634
|View full text |Cite|
|
Sign up to set email alerts
|

Tyrosine kinase potentiates NMDA receptor currents by reducing tonic zinc inhibition

Abstract: Activation of the tyrosine kinase Src potentiates NMDA-receptor currents, which is thought to be necessary for induction of hippocampal long-term potentiation. Although the carboxy(C)-terminal domain of the NR2A subunit contains potential tyrosine phosphorylation sites, the mechanisms by which Src modulates synaptic plasticity and NMDA receptor currents is not fully understood. Here we present evidence from NR1 mutants and splice variants that Src potentiates NMDA-receptor currents by reducing the tonic inhibi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

10
152
0
3

Year Published

2000
2000
2011
2011

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 170 publications
(165 citation statements)
references
References 37 publications
10
152
0
3
Order By: Relevance
“…Furthermore, injection of purified wild-type Pyk2 increases NMDA receptor currents, and this effect is blocked by inhibition of Src. In contrast, the Src-mediated increase in NMDA receptor activity (31)(32)(33) is not antagonized by dominant negative Pyk2 (49). These results place PKC upstream of Pyk2 and Src downstream of Pyk2 in that signaling pathway (49).…”
Section: Discussionmentioning
confidence: 51%
“…Furthermore, injection of purified wild-type Pyk2 increases NMDA receptor currents, and this effect is blocked by inhibition of Src. In contrast, the Src-mediated increase in NMDA receptor activity (31)(32)(33) is not antagonized by dominant negative Pyk2 (49). These results place PKC upstream of Pyk2 and Src downstream of Pyk2 in that signaling pathway (49).…”
Section: Discussionmentioning
confidence: 51%
“…EDTA (pH 7.3, 1-10 M) was added to control solutions containing saturating concentrations of glutamate (20-50 M) or NMDA (200 M) and glycine (10-100 M) to chelate the contaminant Zn 2Ļ© . The ambient Zn 2Ļ© concentration (17) in our solution was Ļ·300 nM (25) and arised predominantly as a contaminant from the NaCl. Tricine was used to buffer Zn 2Ļ© concentrations 0.003-3 M (as described above) and ADA [N-2-acetamidoiminodiacetic acid (Sigma); log stability constants K 1 Ļ­ 7.1 and K 2 Ļ­ 9.22] (1 mM) was used to buffer Zn 2Ļ© concentrations 0.1-100 nM (28) for experiments with NR2A-containing NMDA receptors.…”
Section: Methodsmentioning
confidence: 99%
“…In the majority of cortical neurons, however, addition of Zn 2Ļ© below 30 M had no detectable effect (n Ļ­ 12; data not shown), indicating the lack of high-affinity Zn 2Ļ© modulation of ASICs. Previous studies, however, have reported that most physiological solutions contain contaminating concentrations of Zn 2Ļ© in the range of 20 -50 nM (Paoletti et al, 1997;Amar et al, 2001) or higher (Zheng et al, 1998;Wilkins and Smart, 2002). The lack of effect by low micromolar Zn 2Ļ© may also suggest that a high-affinity Zn 2Ļ© binding site or sites, if any, have already been saturated by contaminating Zn 2Ļ© in the extracellular solutions.…”
Section: Chelation Of Contaminating Znmentioning
confidence: 99%